ArticleScience translational medicine2019

Modulation of the sigma-1 receptor-IRE1 pathway is beneficial in preclinical models of inflammation and sepsis.

Dorian A Rosen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.